Beyond the bench: go for the GLO. by O'Fallon, Liam
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Awards Spur
Excellence in
Research
Since the National Research Service Awards
(NRSA) Program was enacted by Congress
in 1974, the NIH has awarded institutional
training grants to universities and
research centers with the proven com-
mitment and resources to nurture
aspiring young scientists and train
them for careers in biomedical,
behavioral, and clinical research. As
the NIH’s primary means of support-
ing graduate and postdoctoral train-
ing, the since-renamed Ruth L.
Kirschstein NRSA Program, now in
its 30th year, seeks to prepare quali-
fied individuals for careers that will
have a significant impact on the
nation’s research agenda. 
Program directors at the partici-
pating institutions—which are among the
nation’s top public and private research
universities—select the trainees and devel-
op a customized multidisciplinary curricu-
lum of study and research experiences that
together offer research training of the high-
est quality. Topics of study match areas of
interest to the granting institute; at the
NIEHS, these include molecular toxicolo-
gy and epidemiology, neurotoxicology,
toxicogenomics, biostatistics, bioinfor-
matics, human and veterinary pathology,
environmental health sciences, and occu-
pational medicine.
“Topics of research are constantly
evolving,” says Carol Shreffler, who directs
the program at the NIEHS. “Right now in
the NIH, there is a big emphasis on inter-
disciplinary research.” 
In fiscal year 2003, as part of the NRSA
Program, the NIEHS supported 49 institu-
tional training grants totaling more than
$19 million to fund 340 predoctoral and
106 postdoctoral trainees. The beneficiaries
of the program are “the next generation of
scientists,” says Shreffler. “These are the
new, young, vigorous individuals with
innovative ideas who will carry on our
research objectives in the future.”
Groundwork for Growth
Each of the 49 NIEHS grantee institu-
tions has a unique research focus, and all
of them are known as trailblazers in their
particular fields: “Whatever [research]
they are doing, they are doing it better
than anyone,” Shreffler says. Trainees
themselves are given the rare opportunity
to work with and learn from faculty and
principal investigators that are performing
at the top of their fields. 
During her postdoctoral fellowship at
Vanderbilt University, former trainee
Linda Distlerath, now vice president of
global health policy for Merck and
Company, studied the drug-metabolizing
enzyme cytochrome P450. She and her
colleagues sought to better understand
the biochemical basis for genetic differ-
ences in drug metabolism and toxicity,
and published a number of note-
worthy papers, such as a 25 July
1985 report in the Journal of Bio-
logical Chemistry on potential poly-
morphisms involved in oxidative
drug metabolism. “I feel very
privileged to have been a part of
that work—it was one of the sem-
inal studies in the field at the
time,” she says. Distlerath still
speaks reverentially of her mentor
at Vanderbilt, Fred Guengerich.
“He inspired high, high standards
of quality, ethics, integrity, and
validation of data,” she says—
standards she applies today at Merck.
Current trainee Christopher Toscano
knew he wanted to conduct research that
would advance science. Ultimately that
desire brought him to the Johns Hopkins
Bloomberg School of Public Health,
where he is using animal models to study
the molecular mechanisms of calcium sig-
naling pathways that are short-circuited
by lead exposure. 
In particular, Toscano is studying N-
methyl-D-aspartate (NMDA) receptor
proteins present in the membrane of
brain neurons. Lead binds directly to the
NMDA receptors with a high affinity and
inhibits their activation, causing the influx
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Inspired research. Through participation in the
National Research Service Awards Program, the
NIEHS supports the training of hundreds of emerging
scientists who learn the skills and knowledge that will
lead them to answer the most pressing research
questions of today and tomorrow.of calcium—which normally occurs when
the neuron fires—to decrease. Such decreas-
es disrupt calcium signaling pathways,
which can disrupt normal functioning of
the neuron and contribute to learning and
memory deficits seen in childhood lead
exposure, Toscano explains. 
Toscano says he is drawn to this
research because it offers hope for preven-
tion and reversal of lead-induced neurolog-
ical defects. Five percent of U.S. children
have elevated blood lead levels, and
recently it has been shown that chelation
therapy, the primary treatment for lead
poisoning, does not reverse neurological
problems caused by lead exposure, such as
learning disabilities.
Equally passionate about using sci-
ence to improve public health is Lacey
Prouty, a graduate student in the Depart-
ment of Epidemiology at the Harvard
School of Public Health. Her communi-
ty-based study focuses on immigrants of
Caribbean and African descent, a popula-
tion served by the Upham’s Corner
Health Center, which is partnering in the
study. These immigrants live in a Boston
neighborhood notorious for heavy, almost
constant bus and truck traffic and the
resulting diesel exhaust.
Prouty wants to clarify the health
effects of breathing PM2.5 (respirable air-
borne particulate matter measuring 2.5
microns or less in diameter), a diesel
combustion by-product. To monitor
these effects over a 48-hour period, study
participants wear several devices, includ-
ing an ambulatory electrocardiogram
monitor, a monitor that collects a particu-
late sample on a filter, and a personal
aerosol monitor that takes real-time mea-
surements of particulate matter.
“Hopefully we’ll be able to see a corre-
lation between the particulates someone
breathes into their lungs and actual physi-
ological changes in cardiovascular func-
tion,” Prouty says. By comparing results
from healthy and unhealthy participants,
she hopes to show clearly whether the
health effects resulting from particulate
exposure differ in patients who have
underlying cardiovascular and respiratory
conditions, such as high blood pressure or
asthma.
Whereas Prouty’s study involves a
research approach grounded in observa-
tional human data collection, Charles
Morton, a chemical engineer and Ph.D.
candidate in molecular and systems toxi-
cology at the Massachusetts Institute of
Technology Biological Engineering
Division, is busy applying fundamental
engineering principles to the study of
toxicology. He hopes his mathematical
models will one day help toxicology and
pharmacology researchers generate
hypotheses, design experiments, and even
streamline drug development while mini-
mizing the need for human subjects. 
Morton says the models could be used
to study the fate of a molecule, from
administration of or exposure to a toxic
compound, to distribution to tissues
through metabolism, to excretion—“imag-
ine a toxic agent as a signal that enters the
body and gets processed or metabolized,
and the outcome is disease in the human
body,” he explains. 
Many processes, such as binding kinet-
ics, transport phenomena, and metabo-
lism, are involved along the way. “If you
can mathematically analyze the relation-
ship between the input signal—the pattern
of toxic exposure—and the output sig-
nal—the disease state—then you can fig-
ure out what’s going on in between,”
Morton says. 
Such models could be useful in explain-
ing why different patient populations may
be predisposed to developing disease fol-
lowing toxic exposures, or in making useful
predictions of how individuals may respond
to a drug, depending on their metabolic
phenotype. Morton hopes researchers will
one day use his models to explore systems
ranging from exposure to environmental
toxicants to drug–drug interactions. 
Evolution of a Career
No one can say exactly where the work of
Morton, Prouty, and Toscano will lead or
where the trio of bright young scientists
will end up, but it’s clear that the training,
teaching, and inspiration they are soaking
up now will surely have far-reaching
effects, for themselves and others. Just ask
Distlerath. 
Though she no longer conducts
research in a laboratory, Distlerath does
help lead Merck’s efforts to address health
issues in the developing world, especially
concerning the global HIV/AIDS pan-
demic. She directs Merck’s efforts to
build relationships with public and pri-
vate partners to develop and implement
public health and educational programs.
Among these are the company’s partner-
ship with the Bill and Melinda Gates
Foundation to bring HIV/AIDS preven-
tion, treatment, and care to Botswana,
where more than 18,000 people are
enrolled in the largest government-based
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The Scientist has named the NIEHS one of the best places for postdoctoral
researchers to work in its annual survey, published 16 February 2004. Of the
top 15 U.S. institutes, the NIEHS was voted third best.
The survey was open to scientists in the United States, Canada, Israel, and
18 European nations. More than 3,500 postdocs from over 900 institutions
took the online survey. Respondents assessed their working environment
according to 45 criteria under 11 broad topic areas: quality of training, qual-
ity of mentoring, quality of communication, value of the postdoctoral
experience, quality of facilities and infrastructure, remuneration and com-
pensation, availability of funding, information about work and funding
opportunities, networking opportunities, family-related resources and sup-
port, and recreation and social opportunities.
According to Deborah Swope, director of the NIEHS Office of Fellows’
Career Development, the NIEHS Trainees Assembly Steering Committee
deserves most of the credit for the institute’s high ranking. The assembly
was started by fellows and graduate students at the NIEHS in order to foster
the professional development of institute trainees. “The committee’s hard
work and dedication ensures that our fellows receive high-quality training,”
Swope says. “As a result, we now have a number of programs designed to
enhance the professional development of NIEHS fellows. This means that
our fellows not only receive excellent scientific training here, but also learn
the skills that make them well-rounded, competitive scientists prepared for
whatever career path they choose.”
The survey results are available online at http://www.the-scientist.
com/postdoc/postdoc.htm. –Susan M. Booker
NIEHS Tops for PostdocsAIDS treatment program in the African
continent. 
Lab days are also a thing of the past
for former trainee Monica Cooper,
although as a review chemist with the
U.S. Food and Drug Administration
(FDA) she keeps close tabs on other sci-
entists’ laboratory research as she previews
new drug applications. The collaborative
nature of the FDA’s multidisciplinary
review panels reminds Cooper of her
trainee days at the Vanderbilt Center in
Molecular Toxicology, where she studied
how polycyclic aromatic hydrocarbons
(by-products of combustion) react at cer-
tain sites in DNA, where they form
adducts that can lead to carcinogenesis.
“At the center, we did a lot of collabora-
tive work with other labs and scientific
disciplines, which has really helped me in
my work at FDA,” Cooper explains.
In contrast to Cooper and Distlerath,
whose work has diverged from their ini-
tial scientific pursuits over the years,
Nathan Cherrington is still conducting
research in liver toxicity, which is roughly
the same area that originally piqued his
interest as a postdoctoral trainee at the
University of Kansas Medical Center. “I
never had any idea that what I was doing
in graduate school would lead me to
this,” he says. 
The same questions that fascinated
Cherrington a few years ago as a trainee
still command his attention today as an
assistant professor in the Department of
Pharmacology and Toxicology at the
University of Arizona in Tucson. He’s just
taken them a step further. 
As a trainee, Cherrington studied the
regulation of hepatic transporters, agents
that move toxic compounds across cell
membranes, and discovered that normal-
ly occurring bioacids in the human body
turn on a certain transporter known as
multidrug-resistant protein. “Since then,
I’ve been looking at the mechanisms of
transcriptional regulation of that trans-
porter,” Cherrington says. “I’d like to see
if some compound is able to upregulate
the transporter to allow the liver to ‘kick
out’ the toxic compound.” 
Cherrington, like so many other
NRSA trainees past and present, has a
passion to keep uncovering new answers
to scientific puzzles and a willingness to
tread new and difficult terrain to grasp
them. That insatiable desire to keep
searching for scientific answers, along
with the tenacity to work hard and wait
patiently—yet expectantly—for results, is
just what the NRSA training grants are
meant to inspire. –Jennifer Medlin
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Headliners Breast Cancer
NIEHS-Supported Research
Estrogen Exposure and Metabolic Gene Expression
Ansell PJ, Espinosa-Nicholas C, Curran EM, Judy BM, Philips BJ, Hannink M, Lubahn DB.
2004. In vitro and in vivo regulation of antioxidant response element-dependent gene
expression by estrogens. Endocrinology 145:311–317.
Exposure to chemicals that cause oxidative stress can contribute to the devel-
opment of many diseases, including cancer. Many times, however, the
metabolism of such chemicals has proven to be effective in modulating the
degree of oxidative damage. In this paper, NIEHS grantee Dennis B. Lubahn
and colleagues from the University of Missouri–Columbia explore how estro-
gen exposure affects enzyme expression during phase II of metabolism.
Understanding how estrogens regulate phase II detoxification enzymes is
important in explaining why estrogen exposure increases the risk of develop-
ing breast, ovarian, and uterine cancers.
The metabolism of many chemicals involves two distinct phases, each
with characteristic enzymes. Phase I enzymes oxidize many chemicals, there-
by forming intermediates. Phase II detoxification enzymes (such as glu-
tathione-S-transferases and quinone reductase), which are responsible for
metabolizing the products of phase I metabolic reactions, degrade these
reactive intermediates by conjugation or reduction reactions, thereby pro-
tecting cells from oxidative DNA damage. Phase II enzyme expression is regu-
lated by a DNA sequence known as the antioxidant response element. 
The Missouri researchers sought to determine whether and how 17β-estra-
diol regulates gene expression that depends upon the antioxidant response
element. Their results indicate that 17β-estradiol repressed glutathione-S-
transferase gene expression. Additionally, glutathione-S-transferase and
quinone reductase activities in the mouse uterus were significantly lowered in
a dose-dependent manner following 17β-estradiol exposure.
The researchers conclude that 17β-estradiol and other estrogens can
downregulate phase II enzyme activities in the uterus, thus potentially slow-
ing the metabolism of reactive intermediates. This repression may increase
cellular oxidative DNA damage that ultimately can result in the formation of
cancer in estrogen-responsive tissues such as the breast and female reproduc-
tive organs. –Jerry PhelpsEnvironmental Health Perspectives • VOLUME 112 | NUMBER 6 | May 2004 A 351
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In Rochester, New York, where most of the
housing stock was built before 1940, child-
hood lead poisoning rates in many neigh-
borhoods surpass 35%. Health professionals
consider childhood lead poisoning to be the
greatest environmental health risk in the
county, especially for children who live in
low-income urban neighborhoods such as
the Orchard Street community. Now some
Rochester children at risk for lead poisoning
are getting help from the Get the Lead Out
of Orchard Street Community Houses and
Kids (GLO) project.
GLO is coordinated by the Com-
munity Outreach and Education Program
(COEP) at the University of Rochester
Medical Center in collaboration with the
Orchard Street Community Health Center
(OSCHC), the Jay and Orchard Street
Neighborhood Association, the Monroe
County Department of Health, and the
City of Rochester. The OSCHC initiated
GLO in 2002 with the goal of preventing
lead poisoning in children living in that
community by inspecting homes of at-risk
children, educating parents on how to pro-
tect their children from lead exposures, and
encouraging landlords to fix lead hazards.
The COEP conducts surveys with partici-
pating families, develops and
delivers informational materi-
als for parents and property
owners on lead hazards, trains
parents in lead-safe cleaning practices, and
provides expertise in public outreach, edu-
cation, and evaluation strategies.
Project members will eventually inves-
tigate the homes of 100 families with chil-
dren who are patients at the OSCHC.
Home assessments are initiated through
well-child checkups, which has proven to
be an effective strategy, with around a 90%
participation rate. The project is unique in
that it is preventive: most of the children
involved do not yet have elevated blood
lead, although they may live in homes
where hazards are present. For those
homes where lead hazards are found, GLO
provides advocacy and support to tenants
in interactions with property owners, and
encourages property owners to apply for
city and county funds to support lead
remediation.
A key to GLO’s educational efforts was
creating a “lead lab” in an empty house
with lead hazards typical of homes in the
neighborhood. For two months, project
members demonstrated to families, proper-
ty owners, and local policy makers various
low-cost techniques for safe lead cleanup,
lead hazard reduction, and safe work prac-
tices. The lead lab was so effective in reach-
ing diverse audiences that
the city plans to replicate it
in another neighborhood in
Rochester. –Liam O’Fallon
Go for the GLO
Taking the lead on educating about lead. GLO teaches community members about the dangers
of lead-based paint found in older housing, and shows families ways to determine if a hazard is pre-
sent (for instance with a wipe sample, as in the inset), then safely remove it.